Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma-Reply

Affiliations

¹ US Dermatology Partners, Grapevine, Texas.
² Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
³ Department of Dermatology, University of California, Irvine, Irvine, California.

Comment

Howard K Steinman et al. JAMA Dermatol. 2019.

. 2019 Mar 1;155(3):396-397.

doi: 10.1001/jamadermatol.2018.5664.

¹ US Dermatology Partners, Grapevine, Texas.
² Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
³ Department of Dermatology, University of California, Irvine, Irvine, California.

No abstract available

Comment on

Reevaluating Mohs Surgery Appropriate Use Criteria for Primary Superficial Basal Cell Carcinoma.
Steinman HK, Dixon A, Zachary CB. Steinman HK, et al. JAMA Dermatol. 2018 Jul 1;154(7):755-756. doi: 10.1001/jamadermatol.2018.0111. JAMA Dermatol. 2018. PMID: 29516099 No abstract available.
Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma.
Montuno MA, Coldiron BM. Montuno MA, et al. JAMA Dermatol. 2019 Mar 1;155(3):394-395. doi: 10.1001/jamadermatol.2018.3719. JAMA Dermatol. 2019. PMID: 30725082 No abstract available.
Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma.
MacFarlane DF, Perlis C. MacFarlane DF, et al. JAMA Dermatol. 2019 Mar 1;155(3):395-396. doi: 10.1001/jamadermatol.2018.5661. JAMA Dermatol. 2019. PMID: 30725085 No abstract available.
Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma.
Kantor J. Kantor J. JAMA Dermatol. 2019 Mar 1;155(3):395. doi: 10.1001/jamadermatol.2018.4572. JAMA Dermatol. 2019. PMID: 30725088 No abstract available.